Nephrotic syndrome with diffuse membranous glomerulonephritis
ICD-10 N04.2 is a billable code used to indicate a diagnosis of nephrotic syndrome with diffuse membranous glomerulonephritis.
Nephrotic syndrome is characterized by a triad of symptoms: significant proteinuria, hypoalbuminemia, and edema. When associated with diffuse membranous glomerulonephritis, it indicates a specific type of kidney damage where the glomerular capillary walls become thickened due to immune complex deposition. This condition leads to increased permeability of the glomeruli, resulting in the loss of protein in the urine (proteinuria), which can exceed 3.5 grams per day. Patients may also present with hematuria, hypertension, and renal insufficiency. A renal biopsy typically reveals diffuse thickening of the glomerular capillary walls with subepithelial immune complex deposits. Management often involves corticosteroids, immunosuppressive agents, and supportive care to control symptoms and prevent complications such as thromboembolism and infections. Regular monitoring of renal function and proteinuria is essential for assessing disease progression and treatment efficacy.
Detailed clinical notes on symptoms, lab results, and treatment plans.
Patients presenting with edema, proteinuria, and renal insufficiency.
Ensure comprehensive documentation of renal function tests and response to treatment.
Pathology reports detailing biopsy findings and immunofluorescence results.
Biopsy evaluations for suspected glomerular diseases.
Accurate reporting of histological findings is crucial for coding.
Used when a renal biopsy is performed to confirm diagnosis.
Biopsy report must be included in the patient's medical record.
Nephrologists must ensure that the indication for biopsy is clearly documented.
The primary symptoms include significant proteinuria, edema, and low serum albumin levels. Patients may also experience fatigue and weight gain due to fluid retention.
